Damora Therapeutics, Inc. (DMRA) — Financial Flexibility Index
Damora Therapeutics, Inc. (DMRA) has a Financial Flexibility Index of 0.03x as of December 2025. Free cash flow of $566.00K (operating CF $566.00K minus capex $0.00) represents 0% of total liabilities ($20.15 Million). Also explore how fast is Damora Therapeutics, Inc. growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Damora Therapeutics, Inc. Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Damora Therapeutics, Inc. across 8 annual periods. Check DMRA capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Damora Therapeutics, Inc. (2018–2025)
Year-by-year free cash flow to debt coverage for Damora Therapeutics, Inc.. For the full company profile including market capitalisation, see DMRA market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.33x | $-6.73 Million | $-6.73 Million | $20.15 Million | ▲ +95.2% |
| 2024 | -7.00x | $-18.62 Million | $-18.62 Million | $2.66 Million | ▼ -11.8% |
| 2023 | -6.26x | $-36.91 Million | $-36.91 Million | $5.90 Million | ▼ -67.5% |
| 2022 | -3.74x | $-42.74 Million | $-42.93 Million | $11.44 Million | ▲ +64.2% |
| 2021 | -10.43x | $-52.09 Million | $-52.31 Million | $4.99 Million | ▼ -66.8% |
| 2020 | -6.26x | $-38.20 Million | $-38.20 Million | $6.11 Million | ▼ -163.4% |
| 2019 | -2.37x | $-19.33 Million | $-19.33 Million | $8.14 Million | ▲ +22.9% |
| 2018 | -3.08x | $-13.69 Million | $-13.69 Million | $4.44 Million | — |